Prime-boost immunization strategies against HIV.
Barnett
S W
SW
Chiron Corporation, Emeryville, California 94608, USA.
Klinger
J M
JM
Doe
B
B
Walker
C M
CM
Hansen
L
L
Duliège
A M
AM
Sinangil
F M
FM
D016915:AIDS Vaccines / Q000276:immunology*; D000256:Adenoviridae / Q000235:genetics; D000818:Animals; D002986:Clinical Trials as Topic; D003602:Cytotoxicity, Immunologic; D015483:HIV Antibodies / Q000276:immunology; D015699:HIV Envelope Protein gp120 / Q000276:immunology; D019302:HIV Envelope Protein gp160 / Q000276:immunology; D015658:HIV Infections / Q000276:immunology / Q000517:prevention & control*; D006801:Humans; D009500:Neutralization Tests; D002679:Pan troglodytes; D014614:Vaccines, Synthetic / Q000276:immunology
D016915:AIDS Vaccines; D015483:HIV Antibodies; D015699:HIV Envelope Protein gp120; D019302:HIV Envelope Protein gp160; D014614:Vaccines, Synthetic